Calibrium
Calibrium is an emerging privately held biopharmaceutical company.
Business Model:
Revenue: $20.4M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Calibrium Information
Calibrium was acquired by
Novo Nordisk.
The acquisition happend on 2015-08-27.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Ste 300 1260 Hamilton St
City: Aurora
State: ontario
Zip: L4G 1L8
Country: CA
Financial Info
Stage:
convertible note
Raised Last:
$2M
Raised Total:$3M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Calibrium is an emerging privately-held biopharmaceutical company focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases. Calibrium was co-founded by Fritz French, Calibrium’s Chief Executive Officer, and Richard DiMarchi, PhD, Calibirum’s Chief Scientific Officer.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2015 | Convertible Note | 3 | $1.7M |
BioCrossroads Frazier Healthcare Partners 5AM Ventures 5AM Ventures Frazier Healthcare Partners BioCrossroads Frazier Healthcare Partners 5AM Ventures 5AM Ventures Frazier Healthcare Partners |
12/2013 | Venture Round | $1.5M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
